Association of gout and colorectal cancer in Taiwan: a nationwide population-based cohort study.
Jen-Pin ChuangJenq-Chang LeeTzeng-Horng LeuAtik Choirul HidajahYa-Hui ChangChung-Yi LiPublished in: BMJ open (2019)
Similar risks of CRC incidence were observed in patients with and without gout in Taiwan. Allopurinol and colchicine are commonly used as urate-lowering drug and anti-inflammation medication in Taiwan and had been shown to reduce the risk of CRC incidence. Thus, further pharmaco-epidemiological studies should be carried out to specifically assess the role of allopurinol in the relationship between gout and CRC.